FIELD: organic chemistry, chemical technology. SUBSTANCE: invention relates to novel coumarinquinolone carboxylic acids where pyridone system of condensed at positions 3,4-, 6,7- and 7,8- of coumarin system of the general formula (I) where R1,R2 is -NHCH=C(CO2R6)CO; R3 is NO2 or NH2; R4 = R5 is H ; R6 = H or C2H5; R1,R2 is -NHCH=C(CO2R6)CO; R3 = R4 is H; R5 is F; R6 is H or C2H5; R1,R2 is CO(CO2R6)C=CHNH; R3 = R4 = R5 is H; R6 is H or C2H5; R1,R2 = R3,R4 is -NHCH=C(CO2R6)CO; R5 is H ; R6 = H or C2H5; R1 is H or OH; R2 = R5 is H; R3,R4 is -NHCH=C(CO2R6)CO; R6 is H or C2H5; R1 is OH; R2 = R3 is H; R4,R5 is -CO(CO2R6)C=CHNH; R6 is H or C2H5; R1 = R5 is H; R2 is CH3 or CF3; R3,R4 is CO(CO2R6)C=CHNH; R6 is H or C2H5 and their pharmaceutically acceptable salts also. New compounds are inhibitors of tested bacterium strains, they inhibit proliferation of mammary gland cancer, pancreas cancer and larynx cancer cells. Invention describes also methods of synthesis of new compounds. EFFECT: new compounds indicated above, improved method of synthesis, valuable antitumor properties. 21 cl, 10 tbl, 18 ex
Authors
Dates
2001-05-10—Published
1997-07-25—Filed